Sandoz Lifted By Growth In Europe And Biosimilars

First-Half Sales Of Biosimilars Top A Billion Dollars For Sandoz After Double-Digit Increase

 
• By David Wallace
  
Sandoz logo on building
Sandoz has reported its first-half results • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business